Target intelligence / Profile preview

ATPase family AAA domain-containing protein 5 (ATAD5)

Target
ATAD5
Molecular classification
Enzyme (AAA+ ATPase), DNA clamp unloader, Replication factor C (RFC)-like complex component, DNA-binding protein, Chromatin-associated factor
01

Overview

ATPase family AAA domain-containing protein 5 (ATAD5) is an AAA+ ATPase and a key component of a Replication Factor C (RFC)-like complex responsible for unloading the DNA polymerase processivity factor, PCNA, from chromatin following completion of DNA replication. It ensures proper progression and completion of DNA replication, maintains genome stability, and coordinates responses to DNA damage, facilitating repair or apoptosis when necessary. ATAD5 docks with PCNA and other replisome proteins through its conserved ATPase domain and modulates PCNA ubiquitylation by recruiting the deubiquitination machinery. Deficiency of ATAD5 leads to defective PCNA unloading, increased chromatin retention of replication proteins, S-phase progression delays, persistent DNA damage signaling, and heightened sensitivity to DNA-damaging agents. Mutations or reduced expression of ATAD5 are implicated in cancer predisposition through induction of chromosome fragility and genomic instability[1][4][6][5].

Other names
C17orf41ELG1FRAG1chromosome fragility-associated gene 1 proteinenhanced level of genomic instability 1 homologFLJ12735chromosome fragility associated gene 1
02

Mechanism of action

Not applicable (no known drugs specifically target ATAD5 directly); experimentally, ATAD5 loss sensitizes cells to DNA damaging agents due to impaired DNA repair/unloading of PCNA[2].

03

Biological functions

DNA replicationMaintenance of genome integrityRegulation of DNA damage responseUnloading of proliferating cell nuclear antigen (PCNA) from DNARegulation of cell cycle (G2/M phase transition)Promotion of PCNA deubiquitinationFacilitation of DNA repair and replication fork restartApoptosis in response to DNA damage
04

Disease associations

Cancer (genomic instability, tumor suppression)Other diseases involving DNA replication stress or chromosome fragility
05

Safety considerations

Therapeutic targeting may risk increased genome instability, impaired DNA repair, and heightened sensitivity to DNA damage in normal cells
06

Interacting drugs

None currently identified as approved drugs directly targeting ATAD5; however, cells deficient in ATAD5 show hypersensitivity to DNA damaging agents such as methyl methanesulphonate, camptothecin, and mitomycin C[2].
07

Biomarkers

Genomic instability indicators (in contexts of cancer research)Persistent PCNA foci in late cell cycle phases (experimental biomarker for dysfunction)ATAD5 expression levels (potential research biomarker)

Beyond the preview

Go deeper on ATPase family AAA domain-containing protein 5 (ATAD5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATPase family AAA domain-containing protein 5 (ATAD5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call